Egis Pharmaceuticals Overview
- Year Founded
-
1913
- Status
-
Acquired/Merged
- Employees
-
4,800
- Latest Deal Type
-
2ndary - Private
- Financing Rounds
-
2
- Investments
-
3
Egis Pharmaceuticals General Information
Description
Developer of pharmaceutical products dedicated to the treatment of the cardiovascular system, central nervous system, gastroenterology, oncology and women's health. The company offers active ingredients, tablets and injections as well as galenic in liquid and semi-solid formulations.
Contact Information
Website
www.egis.hu(Operating Subsidiary)
Corporate Office
- Kereszturi Ut 30-38
- Budapest, 1106
- Hungary
Corporate Office
- Kereszturi Ut 30-38
- Budapest, 1106
- Hungary
Egis Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Egis Pharmaceuticals Patents
Egis Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026009009-A1 | Troriluzole hydrochloride salts | Pending | 05-Jul-2024 | ||
| EP-4815954-A1 | Process for the preparation of abrocitinib | Pending | 28-Nov-2023 | ||
| WO-2025114733-A1 | Process for the preparation of abrocitinib | Inactive | 28-Nov-2023 | ||
| EP-4750763-A1 | Blarcamesine co-crystals for the manufacture of pharmaceutical dosage form | Pending | 25-Jul-2023 | ||
| US-12018005-B1 | Blarcamesine co-crystals for the manufacture of pharmaceutical dosage form | Active | 25-Jul-2023 | C07D307/14 |
Egis Pharmaceuticals Signals
Egis Pharmaceuticals Investments & Acquisitions (3)
Egis Pharmaceuticals’s most recent deal was a Corporate Asset Purchase with Teva Pharmaceutical Industries (Manufacturing Rights of Topical Product Line in Hungary). The deal was made on 16-Dec-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Teva Pharmaceutical Industries (Manufacturing Rights of Topical Product Line in Hungary) | 16-Dec-2024 | Corporate Asset Purchase | Buildings and Property | ||
| Jadran-Galenski Laboratorij (D-Panthenol brand) | 02-Jun-2017 | Corporate Asset Purchase | Buildings and Property | ||
| Medimpex Hungary | Merger/Acquisition | Pharmaceuticals |
Egis Pharmaceuticals FAQs
-
When was Egis Pharmaceuticals founded?
Egis Pharmaceuticals was founded in 1913.
-
Where is Egis Pharmaceuticals headquartered?
Egis Pharmaceuticals is headquartered in Budapest, Hungary.
-
What is the size of Egis Pharmaceuticals?
Egis Pharmaceuticals has 4,800 total employees.
-
What industry is Egis Pharmaceuticals in?
Egis Pharmaceuticals’s primary industry is Pharmaceuticals.
-
Is Egis Pharmaceuticals a private or public company?
Egis Pharmaceuticals is a Private company.
-
What is the current valuation of Egis Pharmaceuticals?
The current valuation of Egis Pharmaceuticals is .
-
What is Egis Pharmaceuticals’s current revenue?
The current revenue for Egis Pharmaceuticals is .
-
When was Egis Pharmaceuticals acquired?
Egis Pharmaceuticals was acquired on 07-Nov-2013.
-
Who acquired Egis Pharmaceuticals?
Egis Pharmaceuticals was acquired by Servier.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process